| Financial Year |
March 31 2023 |
| Monetary Funds |
73,120,394.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
85,500.00 |
| Accounts Receivable |
150,310,881.09 |
| Advances to Suppliers |
41,702,522.07 |
| Other Receivables |
40,504,617.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,125,284.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
102,583.04 |
| Other Current Assets |
1,035,188.62 |
| Total Current Assets |
307,986,972.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,548,150.70 |
| Long-term Equity Investment |
1,118,125,800.18 |
| Investment Properties |
60,839,656.34 |
| Fixed Assetes |
666,258,041.81 |
| Under-construction Projects |
77,521.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
186,175,710.07 |
| R&D expenses |
-- |
| Goodwill |
102,760,136.16 |
| Long-Term Deferred and Prepaid Expenses |
8,253,481.17 |
| Deferred Income Tax Assets |
27,095,038.10 |
| Other Non-Current Assets |
255,207,559.84 |
| Sub-Total of Non-Current Assets |
2,437,260,377.20 |
| Total Assets |
2,745,247,349.30 |
| Short-Term Loans |
378,617,817.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,403,717.50 |
| Accounts Payable |
72,028,065.44 |
| Accounts Received In Advance |
5,362,041.24 |
| Employee Compensation Payable |
33,480,122.31 |
| Taxes Payable |
8,620,870.33 |
| Interest Payable |
-- |
| Dividend Payable |
655,532.26 |
| Other payables |
297,099,928.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
196,705,546.97 |
| Other Current Liabilities |
735,691.96 |
| Sub-Total of Current Liabilities |
1,005,658,211.01 |
| Long-term Loans |
910,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
53,309,672.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,308,384.66 |
| Deferred Income Tax Liabilities |
96,410,413.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
301,646,876.80 |
| Total Liabilities |
1,307,305,087.81 |
| Paid-In Capital(Or Share Stock) |
313,489,036.00 |
| Capital Surplus |
186,923,673.28 |
| Surplus Reserve |
144,237,459.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
684,624,221.90 |
| Minority Stockholder's Interest |
80,494,077.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,357,448,184.15 |
| Owner's Equity（Stockholder's Equity） |
1,437,942,261.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,745,247,349.30 |
